Outcome | Collateral Score 3 (n = 34) | Collateral Score 0–2 (n = 53) | ORs (95% CIs) | |||||
---|---|---|---|---|---|---|---|---|
Unadjusted | P Valuea | Adjusted for IV-tPA | P Valueb | Adjustedc | P Valueb | |||
Clinical outcome mRS ≤2 at 3 months | 24 (71%) | 23 (43%) | 3.13 (1.252–7.825) | .016 | 2.998 (1.154–7.786) | .024 | 2.985 (1.027–8.673) | .045 |
Intracranial hemorrhage | 4 (12%) | 13 (25%) | 0.41 (0.122–1.385) | .174 | 0.5 (0.141–1.770) | .283 | 0.510 (0.141–1.850) | .306 |
Mortality at 1 month | 2 (6%) | 11 (21%) | 0.239 (0.049–1.153) | .070 | 0.21 (0.041–1.073) | .061 | 0.215 (0.036–1.284) | .092 |